Literature DB >> 14578156

Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo.

Kai-Ming Li1, Rosa Todorovic, Prabu Devanesan, Sheila Higginbotham, Harald Köfeler, Ragulan Ramanathan, Michael L Gross, Eleanor G Rogan, Ercole L Cavalieri.   

Abstract

Studies of estrogen metabolism, formation of DNA adducts, carcinogenicity, cell transformation and mutagenicity have led to the hypothesis that reaction of certain estrogen metabolites, predominantly catechol estrogen-3,4-quinones, with DNA can generate the critical mutations initiating breast, prostate and other cancers. The endogenous estrogens estrone (E1) and estradiol (E2) are oxidized to catechol estrogens (CE), 2- and 4-hydroxylated estrogens, which can be further oxidized to CE quinones. To determine possible DNA adducts of E1(E2)-3,4-quinones [E1(E2)-3,4-Q], we reported previously that the reaction of E1(E2)-3,4-Q with dG produces the depurinating adduct 4-hydroxyE1(E2)-1-N7Gua [4-OHE1(E2)-1-N7Gua] by 1,4-Michael addition (Stack et al., Chem. Res. Toxicol., 1996, 9, 851). We report here that reaction of E1(E2)-3,4-Q with Ade results in the formation of 4-OHE1(E2)-1-N3Ade by 1,4-Michael addition. The N7Gua and N3Ade depurinating adducts formed both in vitro and in rat mammary gland in vivo were analyzed by HPLC with electrochemical detection and, for some samples, by LC/MS/MS. When E2-3,4-Q was reacted with DNA in vitro, the depurinating adducts 4-OHE1(E2)-1-N3Ade and 4-OHE1(E2)-1-N7Gua, which are rapidly lost from DNA by cleavage of the glycosyl bond, were formed (>99% of the total adducts), as well as traces of stable adducts, which remain in DNA unless removed by repair. Similar results were obtained when 4-OHE2 was oxidized by horseradish peroxidase, lactoperoxidase, tyrosinase or phenobarbital-induced rat liver microsomes in the presence of DNA. When 4-OHE2 or E2-3,4-Q was injected into the mammary glands of female ACI rats in vivo and the mammary tissue was excised 1 h later, the depurinating adducts 4-OHE2-1-N3Ade and 4-OHE2-1-N7Gua constituted >99% of the total adducts formed. In addition, 4-OHE2 conjugates formed by reaction of E2-3,4-Q with glutathione were also detected. These results demonstrate that the 4-CE are metabolized to CE-3,4-Q, which react with DNA to form primarily depurinating adducts. These adducts can generate the critical mutations that initiate cancer (Chakravarti et al., Oncogene, 2001, 20, 7945; Chakravarti et al., Proc. Am. Assoc. Cancer Res., 2003, 44, 180).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14578156     DOI: 10.1093/carcin/bgg191

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  59 in total

1.  Mechanism of DNA depurination by carcinogens in relation to cancer initiation.

Authors:  Ercole Cavalieri; Muhammad Saeed; Muhammad Zahid; David Cassada; Daniel Snow; Momcilo Miljkovic; Eleanor Rogan
Journal:  IUBMB Life       Date:  2011-12-09       Impact factor: 3.885

2.  Berries and ellagic acid prevent estrogen-induced mammary tumorigenesis by modulating enzymes of estrogen metabolism.

Authors:  Harini S Aiyer; Ramesh C Gupta
Journal:  Cancer Prev Res (Phila)       Date:  2010-05-25

Review 3.  The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.

Authors:  Ercole Cavalieri; Eleanor Rogan
Journal:  Mol Aspects Med       Date:  2013-08-30

4.  Measurement of 7,8-dihydro-8-oxo-2'-deoxyguanosine metabolism in MCF-7 cells at low concentrations using accelerator mass spectrometry.

Authors:  Sang Soo Hah; Janna M Mundt; Hyung M Kim; Rhoda A Sumbad; Kenneth W Turteltaub; Paul T Henderson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-25       Impact factor: 11.205

5.  Estrogen carcinogenesis: specific identification of estrogen-modified nucleobase in breast tissue from women.

Authors:  Qiang Zhang; Rebecca L Aft; Michael L Gross
Journal:  Chem Res Toxicol       Date:  2008-08-02       Impact factor: 3.739

6.  N-acetylcysteine blocks formation of cancer-initiating estrogen-DNA adducts in cells.

Authors:  Muhammad Zahid; Muhammad Saeed; Mohammed F Ali; Eleanor G Rogan; Ercole L Cavalieri
Journal:  Free Radic Biol Med       Date:  2010-05-31       Impact factor: 7.376

7.  Unbalanced estrogen metabolism in ovarian cancer.

Authors:  Muhammad Zahid; Cheryl L Beseler; James B Hall; Tricia LeVan; Ercole L Cavalieri; Eleanor G Rogan
Journal:  Int J Cancer       Date:  2014-01-25       Impact factor: 7.396

8.  Synthesis and receptor binding in trans-CD ring-fused A-CD estrogens: comparison with the cis-fused isomers.

Authors:  Cristian Dabrota; Muhammad Asim; Christine Choueiri; Ana Gargaun; Ilia Korobkov; Ammara Butt; Kathryn E Carlson; John A Katzenellenbogen; James S Wright; Tony Durst
Journal:  Bioorg Med Chem Lett       Date:  2014-06-27       Impact factor: 2.823

9.  hPMC2 is required for recruiting an ERbeta coactivator complex to mediate transcriptional upregulation of NQO1 and protection against oxidative DNA damage by tamoxifen.

Authors:  S P Sripathy; L J Chaplin; N W Gaikwad; E G Rogan; M M Montano
Journal:  Oncogene       Date:  2008-07-28       Impact factor: 9.867

10.  Benzene and dopamine catechol quinones could initiate cancer or neurogenic disease.

Authors:  Muhammad Zahid; Muhammad Saeed; Eleanor G Rogan; Ercole L Cavalieri
Journal:  Free Radic Biol Med       Date:  2009-11-10       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.